 EMERYVILLE, Calif. , Nov. 09, 2020 GLOBE NEWSWIRE -- Zogenix Nasdaq: ZGNX, a global biopharmaceutical company developing and commercializing rare disease therapies, today announced financial results for the three and nine months ended September 30, 2020 and provided a corporate update. The Company will host a conference call today, Monday, November 9, at 4:30 PM Eastern Time1:30 PM Pacific Time. 